Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Terumo Medical Corporation

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Terumo Medical Corporation

Regulatory records
7
Linked recall entries
1
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 7 FDA records to the applicant name Terumo Medical Corporation. 3 entries are PMA supplements. 4 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 5, 2025 to Aug 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code NIP appears in 4 of the 7 linked filings. The collection spans 3 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P140002, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 950 Elkton Blvd., Elkton, MD, 21921. Recorded on P930038/S107, decision dated Aug 4, 2026.

Changes described in PMA records

P140002/S032: MISAGO(TM) RX Self-expanding Peripheral Stent

FDA’s recorded scope: The Misago RX Self-expanding Peripheral Stent is indicated to improve the luminal diameter in patient with de novo, restenotic and/or occlusive atherosclerotic lesion(s) in the common and/or external iliac artery. The reference vessel diameters range from 4.0 mm to 9.0 mm and the lesion length is up to 120 mm.

Jul 16, 2026 · Panel Track

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Regulatory record history

  1. Angio Seal VIP Vascular Closure Device

    P930038/S107 · PMA supplement
  2. MISAGO(TM) RX Self-expanding Peripheral Stent

    P140002/S032 · PMA supplement
  3. MISAGO RX Self-expanding Peripheral Stent

    P140002/S033 · PMA supplement
  4. MISAGO RX Self-expanding Peripheral Stent

    P140002/S031 · PMA supplement
  5. MISAGO RX Self-expanding Peripheral Stent

    P140002/S030 · PMA supplement
  6. Angio-Seal Vascular Closure Device

    P930038/S106 · PMA supplement
  7. MISAGO RX Self-expanding Peripheral Stent; R2P Misago RX Self-expanding Peripheral Stent System

    P140002/S029 · PMA supplement
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.